Cargando…
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use
BACKGROUND: As in non-infected subjects, statins and aspirin have a pivotal preventive role in reducing the cardiovascular related morbidity and mortality in HIV infected patients. The persistence of immune activation in these subjects, could contribute to accelerate atherosclerosis, therefore, thes...
Autores principales: | Maggi, P., De Socio, G. V., Cicalini, S., D’Abbraccio, M., Dettorre, G., Di Biagio, A., Martinelli, C., Nunnari, G., Rusconi, S., Sighinolfi, L., Spagnuolo, V., Squillace, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534832/ https://www.ncbi.nlm.nih.gov/pubmed/31126301 http://dx.doi.org/10.1186/s12981-019-0226-2 |
Ejemplares similares
-
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
por: Maggi, Paolo, et al.
Publicado: (2017) -
Aspirin: Friend or enemy?
por: Marlicz, Wojciech, et al.
Publicado: (2021) -
Weight Gain: A Possible Side Effect of All Antiretrovirals
por: Taramasso, Lucia, et al.
Publicado: (2017) -
Statins and Cardiomyocyte Metabolism, Friend or Foe?
por: Somers, Tim, et al.
Publicado: (2023) -
Aspirin and Statin Use and the Risk of Gallbladder Cancer
por: Prasai, Kritika, et al.
Publicado: (2021)